| scholarly article | Q13442814 |
| P356 | DOI | 10.1182/BLOOD-2002-07-1957 |
| P698 | PubMed publication ID | 12393488 |
| P50 | author | Peter D Katsikis | Q42434461 |
| Yvonne M Mueller | Q57005064 | ||
| Alfred Kim | Q57041083 | ||
| E. Scott Halstead | Q59679186 | ||
| P2093 | author name string | John D Altman | |
| James Witek | |||
| Paul M Bojczuk | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 1024-1029 | |
| P577 | publication date | 2002-09-19 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | IL-15 enhances survival and function of HIV-specific CD8+ T cells | |
| P478 | volume | 101 |
| Q30385378 | A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes. |
| Q36092834 | Apoptosis in SIV infection. |
| Q36092837 | Apoptosis of HIV-specific CD8+ T cells: an HIV evasion strategy. |
| Q24801374 | Apoptosis of uninfected cells induced by HIV envelope glycoproteins |
| Q41190637 | CD4⁺CD28null T lymphocytes resemble CD8⁺CD28null T lymphocytes in their responses to IL-15 and IL-21 in HIV-infected patients |
| Q33760403 | Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo |
| Q51977322 | Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques. |
| Q97525097 | Current strategies against COVID-19 |
| Q26827712 | Cytokine production and dysregulation in HIV pathogenesis: lessons for development of therapeutics and vaccines |
| Q35917144 | Cytokine therapies in HIV-1 infection: present and future |
| Q36629899 | Cytokine-adjuvanted HIV-DNA vaccination strategies |
| Q26998898 | Developing Combined HIV Vaccine Strategies for a Functional Cure |
| Q53516294 | Differential cyclosporin-A sensitivity on survival and activation of umbilical cord and adult peripheral blood CD4+ T cells. |
| Q34150316 | Differential effects of interleukin-7 and interleukin-15 on NK cell anti-human immunodeficiency virus activity |
| Q42071648 | Early establishment and antigen dependence of simian immunodeficiency virus-specific CD8+ T-cell defects |
| Q51964832 | Efficient augmentation of a long-lasting immune responses in HIV-1 gag DNA vaccination by IL-15 plasmid boosting. |
| Q40615883 | Elite controller CD8+ T cells exhibit comparable viral inhibition capacity, but better sustained effector properties compared to chronic progressors |
| Q36050117 | Expression of interleukin-15 and interleukin-15Rα in monocytes of HIV type 1-infected patients with different courses of disease progression |
| Q36157766 | Follicular Regulatory CD8 T Cells Impair the Germinal Center Response in SIV and Ex Vivo HIV Infection |
| Q38019210 | Functions of IL-15 in anti-viral immunity: multiplicity and variety |
| Q22252422 | HIV infection: first battle decides the war |
| Q33987553 | High dose of plasmid IL-15 inhibits immune responses in an influenza non-human primates immunogenicity model |
| Q61809310 | IL-15 Generates IFN-γ-producing Cells Reciprocally Expressing Lymphoid-Myeloid Markers during Dendritic Cell Differentiation |
| Q35044067 | IL-15 ex vivo overcomes CD4+ T cell deficiency for the induction of human antigen-specific CD8+ T cell responses |
| Q24547172 | IL-15 induces CD4 effector memory T cell production and tissue emigration in nonhuman primates |
| Q57292232 | IL-15 regulates susceptibility of CD4 T cells to HIV infection |
| Q34794353 | IL-15 transpresentation promotes both human T-cell reconstitution and T-cell-dependent antibody responses in vivo |
| Q42453465 | IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses |
| Q40049630 | Immunobiology of the IL-15/IL-15Rα complex as an antitumor and antiviral agent |
| Q98237886 | Immunometabolism and HIV-1 pathogenesis: food for thought |
| Q39170367 | Immunosenescence and hurdles in the clinical management of older HIV-patients |
| Q38050510 | Immunotherapeutic applications of IL-15. |
| Q90290758 | Immunotherapy in People With HIV and Cancer |
| Q38836832 | Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression |
| Q91673318 | Impact of Endemic Infections on HIV Susceptibility in Sub-Saharan Africa |
| Q35760429 | In Vivo Activation of Human NK Cells by Treatment with an Interleukin-15 Superagonist Potently Inhibits Acute In Vivo HIV-1 Infection in Humanized Mice |
| Q51966110 | In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption. |
| Q37143900 | Increased IL-15 production is associated with higher susceptibility of memory CD4 T cells to simian immunodeficiency virus during acute infection |
| Q36202607 | Interleukin-15 (IL-15) Strongly Correlates with Increasing HIV-1 Viremia and Markers of Inflammation |
| Q42027307 | Interleukin-15 increases effector memory CD8+ t cells and NK Cells in simian immunodeficiency virus-infected macaques |
| Q38959284 | Interleukin-15 production by monocyte-derived dendritic cells and T cell proliferation in HIV-infected patients with discordant response to highly active antiretroviral therapy |
| Q50914567 | Interleukin-21 up-regulates interleukin-21R expression and interferon gamma production by CD8+ cells in SHIV-infected macaques. |
| Q54571746 | Juxtacrine function of interleukin-15/interleukin-15 receptor system in tumour derived human B-cell lines. |
| Q34597905 | Lack of IL-15 results in the suboptimal priming of CD4+ T cell response against an intracellular parasite |
| Q35092923 | Levels of CD56+TIM-3- effector CD8 T cells distinguish HIV natural virus suppressors from patients receiving antiretroviral therapy |
| Q97643365 | Metabolic plasticity of HIV-specific CD8+ T cells is associated with enhanced antiviral potential and natural control of HIV-1 infection |
| Q34757680 | Murine oviduct epithelial cell cytokine responses to Chlamydia muridarum infection include interleukin-12-p70 secretion |
| Q37162875 | Neonatal natural killer cell function: relevance to antiviral immune defense |
| Q37140003 | New players in cytokine control of HIV infection |
| Q34570624 | PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection |
| Q37095794 | Peptide-loaded Langerhans cells, despite increased IL15 secretion and T-cell activation in vitro, elicit antitumor T-cell responses comparable to peptide-loaded monocyte-derived dendritic cells in vivo. |
| Q41928139 | Precise identification of a human immunodeficiency virus type 1 antigen processing mutant |
| Q36453570 | Preparing clinical grade Ag-specific T cells for adoptive immunotherapy trials |
| Q51970958 | Role of common gamma chain utilizing cytokines for immune reconstitution in HIV infection. |
| Q37344241 | Role of interleukin-15 in umbilical cord blood transplantation |
| Q36678607 | T cells expanded in presence of IL-15 exhibit increased antioxidant capacity and innate effector molecules |
| Q35613792 | T-cell and neuronal apoptosis in HIV infection: implications for therapeutic intervention |
| Q30406147 | The cytokine network of acute HIV infection: a promising target for vaccines and therapy to reduce viral set-point? |
| Q43578138 | The immune response to the RT181-189 epitope in HIV-1-infected patients is associated with viral sequence polymorphism flanking the epitope |
| Q36960508 | The potential of topical DNA vaccines adjuvanted by cytokines |
| Q81653120 | To kill or be killed: how HIV exhausts the immune system |
Search more.